Rare diseases
Investigational molecules
Locations
B3-101 Biobay 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Pilot Free Trade Zone, 215123
Medilink Therapeutics (Suzhou) Co. Ltd. focuses its clinical research on advanced solid tumors, with trials centered on patients whose cancers have progressed beyond earlier treatment settings.
The sponsor’s trial portfolio reflects interest in difficult-to-treat malignancies across multiple tumor types, with an emphasis on therapeutic development in cancer treatment.
Medilink Therapeutics (Suzhou) Co. Ltd. runs clinical trials in conditions such as Neoplasm malignant, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
